once-weekly semaglutide in persons with obesity and knee osteoarthritis ameliorates progression through a weight loss-independent metabolic restoration mechanism: Cell Metabolism Obesity is a major risk

GLP-1 medicines were first made to help with diabetes and weight loss, but they might also have some benefits for people with Crohns disease, says Raseen Tariq, MD, a gastroenterologist and an assistant professor of medicine in the division of gastroenterology, hepatology, and nutrition at Virginia Commonwealth Universitys school of medicine in Richmond

Louis Daily newsletter for a smart, succinct guide to local news from award-winning journalists Sarah Fenske and Ryan Krull

The mistake is pretending only one lane exists

Prolonged Neutrophilia Is Associated With Worse Outcomes After Esophagectomy

But of course it is